MedPath

BI-PEGLYTE

BI-PEGLYTE

Approved
DIN Number

02326302

Drug Class

Human

Market Date

Jun 6, 2010

Company
HC

pendopharm division of pharmascience inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02326302
AIG Number0652579001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A06AB52 BISACODYL, COMBINATIONS
Product Specifications
Dosage FormTablet (Delayed-Release) ,  Powder For Solution ,  Kit
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

BISACODYLActive
Strength: 5 MG / TAB
Monograph: BISACODYL
POLYETHYLENE GLYCOL 3350Active
Strength: 59.55 G / SACHET
Monograph: POLYETHYLENE GLYCOL 3350
POTASSIUM CHLORIDEActive
Strength: 0.76 G / SACHET
Monograph: POTASSIUM CHLORIDE
SODIUM BICARBONATEActive
Strength: 1.69 G / SACHET
Monograph: SODIUM BICARBONATE
SODIUM CHLORIDEActive
Strength: 1.46 G / SACHET
Monograph: SODIUM CHLORIDE
SODIUM SULFATEActive
Strength: 5.74 G / SACHET
Monograph: SODIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.